Loading company…
Topica Pharmaceuticals develops topical treatments for fungal infections of the toenail and nail bed.
Topica Pharmaceuticals develops topical treatments for onychomycosis, or fungal infections of the toenail and nail bed. The company is based in Palo Alto, US, and has reached Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in